« All Events

Please join us virtually to hear updates and sustainment goals for the AIM Hypertension Bundle!

Over three-quarters of pregnant patients with hypertension at Beth Israel Deaconess Medical Center and Cambridge Health Alliance are treated within 1 hour. Join this webinar (which will be recorded) to hear their lessons learned, as well as PNQIN’s new efforts to support hospitals with the sustainment of this and our other previous bundles!

Register here!

Quick Details

Date May 6th 2025, 11:00 am - 12:00 pm
Location
Zoom
Speaker Guidelines for Inclusive Content & Delivery https://pnqinma.org/wp-content/uploads/2026/06/V1_PNQIN-Speaker-Guidelines-for-Inclusive-Content-Delivery.pdf PNQIN Speaker Guidelines for Inclusive Content & DeliveryV1, March 2026 These guidelines support inclusive speaker recruitment, educational content, and representation that reflect the diversity of PNQIN’s membership. Our...
Communication
Association of Prenatal Fentanyl Exposure With Neonatal Opioid Withdrawal Syndrome Severity Abstract OBJECTIVE: Opioid use disorder (OUD) in pregnancy has increased substantially, with illicitfentanyl now the most common illicit opioid. Limited data exist on the impact of antenatalfentanyl exposure on...
Neonatal Abstinence Syndrome Opioid and Substance Use Disorders
There is no excerpt because this is a protected post.
Updated Guidance from ACOG: Zuranolone and Brexanolone for Treatment of Postpartum Depression Co-authored by our MA PMHC Bundle Lead, Dr. Tiffany Moore Simas, this Clinical Practice Update provides revised guidance on the use of both Zuranolone and Brexanolone for management of...